The Department of Social Services MO HealthNet Division (Medicaid) adopted an emergency rule for the Pharmacy Reimbursement Allowance (PRA). The emergency amendment was filed on June 23 and takes effect on July 8 and expires February 26, 2026.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Department of Health and Senior Services (DHSS) renewed the naloxone standing order with a June 2, 2026, expiration date.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The General Assembly adjourned on May 16.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
MO HealthNet (Medicaid) is conducting a survey regarding the implementation of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act’s prescription drug monitoring program mandate. The SUPPORT Act required that states mandate that covered providers consult a qualified prescription drug monitoring program (PDMP) before prescribing controlled substances to covered individuals. States must report annual data about the use of PDMPs by covered providers before prescribing controlled substances to the Department of Health and Human Services (HHS).
Also in Missouri, effective January 9, 2025, the MO HealthNet Division (MHD) carved-out certain drugs from the 340B Drug Pricing Program reimbursement. It was necessary to allow the state to collect supplemental and value-based agreement rebates on certain therapies. The state cannot collect federal, supplemental, or value-based agreement rebates when a covered entity utilizes 340B stock.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy amended rule 20 CSR 2220-4.010 governing new Board fees, that took effective on October 30.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
MO HealthNet completed the annual review of all drug coverage criteria for the Prior Authorization Process.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Consolidated Health Care Plan (MCHCP) issued an Emergency Rule clarifying member eligibility and responsibility for charges, effective January 1, 2025.
Also in Missouri, the Department of Commerce and Insurance Board of Pharmacy posted a list of fee increases that went into effect on October 30, 2024.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Due to numerous questions on the drug shortages caused by the recent hurricanes, the Board of Pharmacy issued guidance to assist licensees.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Looking for ways to reduce healthcare costs for Missourians, six Senators have been named to the newly formed Senate Interim Committee on Driving Down the Cost of Healthcare. The committee will issue a report and recommendations by the end of the year
Also in Missouri, effective October 1, the MO HealthNet Pharmacy program discontinued coverage for at-home COVID-19 tests dispensed as a kit for at-home use. COVID-19 testing will continue to be covered for MO HealthNet participants when administered by a MO HealthNet enrolled provider.
Finally in Missouri, St. Louis Public Radio Morning Edition published online a PBM reform story about St. Louis-based Express Scripts being sued by the Federal Trade Commission (FTC). Pharmacists and patient advocates are advocating for lower drug prices.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
